Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Chronic liver injury characteristically results in hepatic inflammation, which represents a prerequisite for organ fibrosis. Although NKT cells are abundantly present in liver and involved in hepatic inflammation, molecular mechanisms of their recruitment in liver fibrosis remained elusive. We hypothesized that chemokine receptor CXCR6 and its ligand CXCL16 control NKT cell migration and functionality in liver fibrosis. In patients with chronic liver diseases (n = 58), CXCR6 and CXCL16 expression was intrahepatically upregulated compared with controls. In murine liver, Cxcl16 was strongly expressed by endothelium and macrophages, whereas lymphocyte populations (NKT, NK, CD4 T, CD8 T cells) expressed CXCR6. Intravital two-photon microscopy imaging of Cxcr6+/gfp and Cxcr6gfp/gfp mice and chemotaxis studies in vitro revealed that CXCR6 specifically controls hepatic NKT cell accumulation during the early response upon experimental liver damage. Hepatic invariant NKT cells expressed distinct proinflammatory cytokines including IFN-γ and IL-4 upon injury. CXCR6-deficient mice were protected from liver fibrosis progression in two independent experimental models. Macrophage infiltration and protein levels of inflammatory cytokines IFN-γ, TNF-α, and IL-4 were also reduced in fibrotic livers of Cxcr6−/− mice, corroborating that hepatic NKT cells provide essential cytokine signals perpetuating hepatic inflammation and fibrogenesis. Adoptive transfer of NKT cells, but not CD4 T cells, isolated from wild type livers restored hepatic fibrosis in Cxcr6−/− mice upon experimental steatohepatitis. Our results demonstrate that hepatic NKT cells accumulate CXCR6-dependent early upon injury, thereby accentuating the inflammatory response in the liver and promoting hepatic fibrogenesis. Interfering with CXCR6/CXCL16 might therefore bear therapeutic potential in liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this model, fibrosis amelioration appeared to depend on effects on NK-cells rather than direct modulation of macrophages, although macrophage phenotypes were not extensively characterized.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“A similar protective effect was observed in a MASH model, supporting the relevance of intercellular crosstalk in shaping macrophage function.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“C-X-C chemokine receptor 6 (CXCR6) is mainly expressed in natural killer (NK) cells, whereas its ligand CXCL16 is expressed in macrophages and endothelial cells, and both are also upregulated in patients with chronic liver disease.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [87]
In the citing paper
“Mechanistically, several ligand-receptor pairs mediate the effects of NKT cells, including LIGHT-HVEM (which promotes hepatocyte steatosis) and CXCL16-CXCR6 (which promotes hepatic NKT cell recruitment and liver fibrosis).93,94”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [94]
In the citing paper
“NKT cells are much more abundant in mouse livers than in humans, and they promote NASH, fibrosis and carcinogenesis in experimental models.86,96,97”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [97]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210 · cited 1×
“have applied this method for liver in living mice, mostly because of artifacts created by breath movements and the autofluorescence of hepatic tissue (27, 30).”
MethodGodfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J., & Kaer, L. V. (2004) · Nature Reviews Immunology · doi:10.1038/nri1309 · Cited by 1,182 · cited 6×
“ferent types of proinflammatory cytokines, including IL-4, IFN-g, and TNF-a (14).”
BackgroundInfluentialTracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887 · cited 1×
“Ab or a-GalCer (17), resulting in low hepatic NKT cell numbers in chronic injury, such as fibrosis (12).”
BackgroundKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 2×
“Hepatocytes were isolated from murine livers by conventional collagenase perfusion methodology (6).”
BackgroundMethodSelf-citationIntravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids
Geissmann, F., Cameron, T. O., Sidobre, S., Manlongat, N., Kronenberg, M., Briskin, M. J., Dustin, M. L., & Littman, D. R. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030113 · Cited by 680 · cited 7×
“(15) and in macrophages or dendritic cells of other organs (22).”
BackgroundResultInfluentialBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · cited 4×
“Biochemical assays and gene and protein expression studies were performed as described previously (8, 24, 25).”
MethodInfluentialSelf-citationCritical contribution of liver natural killer T cells to a murine model of hepatitis
Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H., & Okumura, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040566697 · Cited by 539 · cited 1×
“3C) because of an overwhelming influx of monocytes–macrophages and apoptosis of activated NKT cells (12, 28).”
BackgroundAbel, S., Hundhausen, C., Mentlein, R., Schulte, A., Berkhout, T. A., Broadway, N., Hartmann, D., Sedlacek, R., Dietrich, S., Muetze, B., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6362 · Cited by 437
Self-citationFunctional Innervation of Hepatic iNKT Cells Is Immunosuppressive Following Stroke
Wong, C. H. Y., Jenne, C. N., Lee, W.-Y., Léger, C., & Kubes, P. (2011) · Science · doi:10.1126/science.1210301 · Cited by 396 · cited 3×
“in the liver and are involved in systemic immune surveillance mechanisms (27).”
BackgroundMethodShimaoka, T., Kume, N., Minami, M., Hayashida, K., Kataoka, H., Kita, T., & Yonehara, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000761200 · Cited by 333 · cited 2×
“1C), as observed before for tissue macrophages from other organs (22).”
BackgroundZimmermann, H. W., Seidler, S., Nattermann, J., Gassler, N., Hellerbrand, C., Zernecke, A., Tischendorf, J. J. W., Luedde, T., Weiskirchen, R., Trautwein, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011049 · Cited by 310 · cited 1×
“Liver biopsies or explants of cirrhotic livers were scored and processed as described previously (7).”
BackgroundSelf-citationAccumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
Syn, W.-K., Oo, Y. H., Pereira, T. A., Karaca, G. F., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., Guy, C. D., Fearing, C. M., et al. (2010) · Hepatology · doi:10.1002/hep.23599 · Cited by 283 · cited 2×
“In addition, Cd1d mice lacking NKT cells were protected in thioacetamide-induced liver fibrosis (18) and in nonalcoholic steatohepatitis (19).”
BackgroundNKT-Associated Hedgehog and Osteopontin Drive Fibrogenesis in Non-Alcoholic Fatty Liver Disease
Syn, W.-K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301857 · Cited by 266 · cited 1×
“Prior studies have suggested hepatic endothelium as the major source of CXCL16 in the liver in homeostasis (15), and cholangiocyte-derived CXCL16, secreted following Hedgehogpathway-dependent crosstalk with HSC, as a strong stimulus for NKT cell migration in injury (31, 32).”
BackgroundKarlmark, K. R., Zimmermann, H. W., Roderburg, C., Gassler, N., Wasmuth, H. E., Luedde, T., Trautwein, C., & Tacke, F. (2010) · Hepatology · doi:10.1002/hep.23894 · Cited by 249 · cited 1×
“Biochemical assays and gene and protein expression studies were performed as described previously (8, 24, 25).”
MethodSelf-citationSafadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239 · cited 7×
“liver fibrosis via activating hepatic stellate cells (HSC) (9), whereas NK cells are capable of promoting HSC apoptosis and are thus considered antifibrotic (10, 11).”
BackgroundInfluentialShimaoka, T., Nakayama, T., Fukumoto, N., Kume, N., Takahashi, S., Yamaguchi, J., Minami, M., Hayashida, K., Kita, T., Ohsumi, J., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003465 · Cited by 229 · cited 1×
“form, CXCL16 functions as an adhesion molecule, anchoring activated NKT cells (36).”
BackgroundHeydtmann, M., Lalor, P. F., Eksteen, J. A., Hübscher, S. G., Briskin, M., & Adams, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1055 · Cited by 226 · cited 4×
“Although increased numbers of CXCR6-expressing circulating and hepatic lymphocytes have been described in cases of hepatitis C–infected patients (21), the relevance of this chemokine-”
BackgroundResultInfluentialUnutmaz, D., Xiang, W., Sunshine, M. J., Campbell, J., Butcher, E., & Littman, D. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3284 · Cited by 217 · cited 2×
“To study CXCR6 expression by different cells in the liver, we used Cxcr6 mice in which the Cxcr6 coding region was replaced by GFP cDNA (23).”
BackgroundMethodUpdate on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques
Tacke, F., & Weiskirchen, R. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.92 · Cited by 205 · cited 1×
“Hepatic stellate cells were obtained by FACS sorting via negative staining for CD45, F4/80, CD11b, Ly6G, and positive autofluorescence in UV-channel (26).”
MethodSelf-citationPark, O., Jeong, W.-I., Wang, L., Wang, H., Lian, Z.-X., Gershwin, E. M., & Gao, B. (2009) · Hepatology · doi:10.1002/hep.22813 · Cited by 189 · cited 10×
“Concordantly, the preactivation of hepatic NKT cells by a-GalCer accelerated liver fibrosis in experimental murine models (12).”
BackgroundResultInfluentialHeymann, F., Hammerich, L., Storch, D., Bartneck, M., Huss, S., Rüsseler, V., Gassler, N., Lira, S. A., Luedde, T., Trautwein, C., et al. (2012) · Hepatology · doi:10.1002/hep.24764 · Cited by 177 · cited 3×
“Biochemical assays and gene and protein expression studies were performed as described previously (8, 24, 25).”
MethodSelf-citationNKp46-Mediated Killing of Human and Mouse Hepatic Stellate Cells Attenuates Liver Fibrosis
Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-tair, L., Safadi, R., & Mandelboim, O. (2012) · Gut · doi:10.1136/gutjnl-2011-301400 · Cited by 173 · cited 1×
“liver fibrosis via activating hepatic stellate cells (HSC) (9), whereas NK cells are capable of promoting HSC apoptosis and are thus considered antifibrotic (10, 11).”
BackgroundVisualizing Hepatitis C Virus Infections in Human Liver by Two-Photon Microscopy
Liang, Y., Shilagard, T., Xiao, S., Snyder, N., Lau, D., Cicalese, L., Weiss, H., Vargas, G., & Lemon, S. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.050 · Cited by 171 · cited 1×
“application in liver has been demonstrated using frozen sections of human livers infected with hepatitis C virus (29).”
BackgroundPeptide-Functionalized Gold Nanorods Increase Liver Injury in Hepatitis
Bartneck, M., Ritz, T., Keul, H. A., Wambach, M., Bornemann, J., Gbureck, U., Ehling, J., Lammers, T., Heymann, F., Gassler, N., et al. (2012) · ACS Nano · doi:10.1021/nn302502u · Cited by 167
Self-citationde Lalla, C., Galli, G., Aldrighetti, L., Romeo, R., Mariani, M., Monno, A., Nuti, S., Colombo, M., Callea, F., Porcelli, S. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1417 · Cited by 151 · cited 1×
“sion by secreting HSC-activating cytokines IL-4 and IL-13 (39), similar to observations from patients with chronic hepatitis B (40) and consistent with the cytokine expression pattern we identified in hepatic NKT cells isolated from murine injury models in WT, but not Cxcr6 mice.”
ResultJeong, W.-I., Park, O., Suh, Y.-G., Byun, J.-S., Park, S.-Y., Choi, E., Kim, J.-K., Ko, H., Wang, H., Miller, A. M., et al. (2011) · Hepatology · doi:10.1002/hep.24190 · Cited by 142 · cited 1×
“However, particularly in early phases of carbon tetrachloride (CCl4)–induced fibrosis, NKT cells can also be protective by restricting HSC activation, suggesting that the net effect of NKT cells in liver scarring depends on the balance between protective and detrimental consequences of NKT cell activation (12, 20).”
BackgroundChemokine-directed immune cell infiltration in acute and chronic liver disease
Karlmark, K. R., Wasmuth, H. E., Trautwein, C., & Tacke, F. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.2.233 · Cited by 134
Self-citationDown‐regulation of the invariant Vα14 antigen receptor in NKT cells upon activation
Harada, M., Seino, K., Wakao, H., Sakata, S., Ishizuka, Y., Ito, T., Kojo, S., Nakayama, T., & Taniguchi, M. (2004) · International Immunology · doi:10.1093/intimm/dxh023 · Cited by 134
Amelioration of hepatic fibrosis by NK cell activation
Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R. (2011) · Gut · doi:10.1136/gut.2010.211136 · Cited by 127 · cited 1×
“liver fibrosis via activating hepatic stellate cells (HSC) (9), whereas NK cells are capable of promoting HSC apoptosis and are thus considered antifibrotic (10, 11).”
BackgroundW. Zimmermann, H., & Tacke, F. (2011) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152811798104890 · Cited by 121 · cited 4×
“Liver inflammation in general is tightly controlled by chemokines, which are peptide mediators that stimulate chemotaxis of target cells through specific G protein–coupled receptors (4).”
BackgroundInfluentialSelf-citationHobbs, J. A., Cho, S., Webb, T. J., Sriram, V., Zhang, J., Xu, M., & Brutkiewicz, R. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10746-10754.2001 · Cited by 104
Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production†
Omenetti, A., Syn, W., Jung, Y., Francis, H., Porrello, A., Witek, R. P., Choi, S. S., Yang, L., Mayo, M. J., Gershwin, M. E., et al. (2009) · Hepatology · doi:10.1002/hep.23019 · Cited by 101 · cited 1×
“Prior studies have suggested hepatic endothelium as the major source of CXCL16 in the liver in homeostasis (15), and cholangiocyte-derived CXCL16, secreted following Hedgehogpathway-dependent crosstalk with HSC, as a strong stimulus for NKT cell migration in injury (31, 32).”
BackgroundJin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2011) · Hepatology · doi:10.1002/hep.23983 · Cited by 100 · cited 2×
“In HBVtransgenic mice, NKT cell activation promoted fibrosis progres- sion by secreting HSC-activating cytokines IL-4 and IL-13 (39), similar to observations from patients with chronic hepatitis B (40) and consistent with the cytokine expression pattern we identified in hepatic NKT cells isolated from murine injury mo…”
ResultBoisvert, J., Kunkel, E. J., Campbell, J. J., Keeffe, E. B., Butcher, E. C., & Greenberg, H. B. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00328-8 · Cited by 98 · cited 1×
“cally injured, especially cirrhotic, human livers compared with control tissue, which is consistent with prior studies mainly conducted in hepatitis C–induced cirrhosis (21, 34).”
ResultAjuebor, M. N., Aspinall, A. I., Zhou, F., Le, T., Yang, Y., Urbanski, S. J., Sidobre, S., Kronenberg, M., Hogaboam, C. M., & Swain, M. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8027 · Cited by 84 · cited 1×
“Experimental studies using Con A or a-GalCer demonstrated that NKT cell activation contributes to acute hepatitis (15, 16, 38), likely by releasing various proinflammatory cytokines and via Fas-mediated cell lysis (4).”
BackgroundCD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice
Ishikawa, S., Ikejima, K., Yamagata, H., Aoyama, T., Kon, K., Arai, K., Takeda, K., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.022 · Cited by 64 · cited 2×
“In addition, Cd1d mice lacking NKT cells were protected in thioacetamide-induced liver fibrosis (18) and in nonalcoholic steatohepatitis (19).”
BackgroundXu, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.4979 · Cited by 28 · cited 1×
“Preliminary experiments inhibiting CXCL16 by neutralizing Abs in acute liver failure models in mice indicated the general feasibility of such an approach (43).”
BackgroundAmeliorated ConA-Induced Hepatitis in the Absence of PKC-theta
Fang, X., Wang, R., Ma, J., Ding, Y. P., Shang, W., & Sun, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031174 · Cited by 27 · cited 1×
“Experimental studies using Con A or a-GalCer demonstrated that NKT cell activation contributes to acute hepatitis (15, 16, 38), likely by releasing various proinflammatory cytokines and via Fas-mediated cell lysis (4).”
BackgroundTargeting the diverse immunological functions expressed by hepatic NKT cells
Duwaerts, C. C., & Gregory, S. H. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.584874 · Cited by 19 · cited 1×
“The functional role of NKT cells, which are abundantly present in the liver and constitute ∼30% of the hepatic lymphocytes, in liver fibrogenesis is less clear (12, 13).”
Background
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Self-citation
Metadata
- Authors
- Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., Ludwig, A., Luedde, T., Trautwein, C., & Tacke, F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- University of Bonn (DE)
- Corresponding author
- Wehr, Alexander
- Baeck, Christer
- Heymann, Felix
- Hammerich, Linda
- Luedde, Tom
- Trautwein, Christian
- Tacke, Frank
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05
- Volume
- 190
- Issue
- 10
- Pages
- 5226-5236
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149878896
- Cited by
- 268
- References
- 43
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 20 · 2023: 28 · 2022: 31 · 2021: 32 · 2020: 20 · 2019: 18 · 2018: 20 · 2017: 18 · 2016: 9 · 2015: 20 · 2014: 19 · 2013: 4
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- CXCR6, CXCL16, NKT cells, liver fibrosis, liver inflammation, chemokine receptors, macrophage infiltration, interferon-gamma, IL-4, TNF-α, steatohepatitis, chronic liver injury
- MeSH terms
- Chemokine CXCL16, Receptors, CXCR6, Animals, Cell Movement, Cells, Cultured, Fatty Liver, Humans, Inflammation, Interferon-gamma, Liver, Liver Cirrhosis, Liver Diseases, Macrophages, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Interleukin-4, Up-Regulation, Mice, Knockout, Adoptive Transfer, Hepatocytes, Mice, Receptors, CXCR, Chemokine CXCL6, Natural Killer T-Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.